Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts. - Wikidata - wikimedia - TriplyDB

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.

http://www.wikidata.org/entity/Q34487409

about

Pharmacotherapy of multiple myeloma: an economic perspective.Idarubicin containing regimen in multiple myeloma: preliminary results of a pilot study using a modified "TANDEM" transplant program.Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients.

P2860

Q35095205-4A6507B2-0508-430D-A9B1-94D97D8EB4F1 Q44398780-860BDA0E-2FD2-42D3-A4B5-D1D141C257A4 Q44857535-0C3D8BDC-AA11-4257-BE1E-5B16F3078CC6

P2860

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.

http://www.wikidata.org/entity/Q34487409

description

2001 nî lūn-bûn

@nan

2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.

@ast

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.

@en

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.

@nl

type

label

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.

@ast

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.

@en

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.

@nl

prefLabel

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.

@ast

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.

@en

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.

@nl

P1433

Q34487409-D11A9373-4B2E-46FC-A76C-70936E91E96F

P1476

Q34487409-36F95509-9C89-44E4-B990-A44FF8A7F626

P2093

Q34487409-12029271-D5EB-45A5-9127-1A4A9410DE58

Q34487409-986915E7-A73F-456E-AE53-5EC0673E6B95

Q34487409-C503EAA1-C428-443D-AB52-7C781F7D8487

P2860

Q34487409-2685C672-939D-4945-AF89-2BA3449BF760

Q34487409-2C8BF191-8216-4FA6-95BC-61EF9393A7F9

Q34487409-4706D26A-794A-4D46-978C-52C7A1F88B86

Q34487409-56A500D1-1D62-4B57-8BF7-C22B7AB30865

Q34487409-5D91EA3C-BE7A-4ED6-9649-742D346B632A

Q34487409-63A284F6-E088-4AFB-841E-AE07A77AAFBF

Q34487409-6BACB779-E0ED-404B-AC9C-B8623C487381

Q34487409-784F082E-E807-4C8C-BFC1-48F82D1D79A9

Q34487409-79B6451E-E567-40F9-BEBC-9016147BEA6B

Q34487409-8108CE33-8EFF-4D24-AC61-AC8ACA5CB53C

P2888

Q34487409-E57044D2-8CA6-46BB-8E4B-A665ADB098C9

P304

Q34487409-3A777C17-2413-407B-BB63-8AFBC621909D

P31

Q34487409-136AB6F3-D5AA-40F2-BB14-CBF673297DC4

P356

Q34487409-2A831A59-DEB6-4508-928A-E80056AB298B

P407

Q34487409-03727BC0-19CC-4BEF-984D-DE5C8D5F20B3

P433

Q34487409-67B147D7-7F84-4547-959F-687DBDA59F38

P478

Q34487409-01470E8E-169D-4428-A2D6-B822069DBC98

P577

Q34487409-DD29A473-9497-4AEC-A77C-AC982388BBD6

P5875

Q34487409-E62B6870-4F83-47F7-9FAB-599C38853C14

P6179

Q34487409-0A8E4B75-FC73-4C0F-A413-B85F6B8215D2

P698

Q34487409-9B7E560C-8820-423B-8E53-18A53BBF7165

P921

Q34487409-39E0A2C8-0C6A-4943-85C8-9CD6D3082C4E

P356

P1433

Bone Marrow Transplantation

P1476

Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.

@en

P2093

Lazarus HM

http://www.w3.org/2001/XMLSchema#string

Simic A

http://www.w3.org/2001/XMLSchema#string

Vesole DH

http://www.w3.org/2001/XMLSchema#string

P2860

Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma

Intensive treatment for multiple myeloma: where do we stand?

Antitumor activity of thalidomide in refractory multiple myeloma.

Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy.

A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death.

Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melph

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.

Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome.

Tumor vaccination strategies combined with autologous peripheral stem cell transplantation.

Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation.

P2888

P304

725-735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BMT.1703254

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11575895

http://www.w3.org/2001/XMLSchema#string

P6179

1038384133

http://www.w3.org/2001/XMLSchema#string

P698

11781623

http://www.w3.org/2001/XMLSchema#string

P921

autotransplantation